10-Q Filing

STREAMEX CORP. CIK: 1530766 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001185185-20-001080`
Period End Date	20200630
Filing Date	20200806
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	biosig20200630_10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 64 Cash Flow Statement 72 Stockholders Equity 55

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$36.93M	USD	Point-in-time
Cash	`Cash`	$12.11M	USD	Point-in-time
Inventory	`InventoryNet`	$800.00K	USD	Point-in-time
Inventory	`InventoryNet`	$577.69K	USD	Point-in-time
Vendor deposits	`DepositAssets`	-	USD	Point-in-time
Vendor deposits	`DepositAssets`	$470.83K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$141.22K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$453.82K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.83M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$38.65M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$174.74K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$180.37K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$513.46K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$714.34K	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableRelatedPartiesCurrent`	$97.64K	USD	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$355.03K	USD	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$364.54K	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableRelatedPartiesCurrent`	$39.67K	USD	Point-in-time
Trademarks	`IndefiniteLivedTrademarks`	$1.12K	USD	Point-in-time
Trademarks	`IndefiniteLivedTrademarks`	$1.12K	USD	Point-in-time
Prepaid expenses, long term	`PrepaidExpenseNoncurrent`	$14.00K	USD	Point-in-time
Prepaid expenses, long term	`PrepaidExpenseNoncurrent`	$27.41K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$101.84K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$101.84K	USD	Point-in-time
Total assets	`Assets`	$14.22M	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$39.81M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts payable and accrued expenses, including $97,645 and $39,674 to related parties as of June 30, 2020 and December 31, 2019, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.10M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts payable and accrued expenses, including $97,645 and $39,674 to related parties as of June 30, 2020 and December 31, 2019, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.49M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$128.48K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$67.45K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	29.13M	shares	Point-in-time
Lease liability, short term	`OperatingLeaseLiabilityCurrent`	$435.29K	USD	Point-in-time
Lease liability, short term	`OperatingLeaseLiabilityCurrent`	$412.29K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	23.32M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.61M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	29.13M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	23.32M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.03M	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$88.57K	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$311.13K	USD	Point-in-time
Total debt	`LiabilitiesNoncurrent`	$3.70M	USD	Point-in-time
Total debt	`LiabilitiesNoncurrent`	$2.34M	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred Stock	`TemporaryEquityCarryingAmountAttributableToParent`	$105.00K	USD	Point-in-time
Preferred Stock	`TemporaryEquityCarryingAmountAttributableToParent`	$215.00K	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 29,126,663 and 23,323,087 issued and outstanding as of June 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$23.32K	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 29,126,663 and 23,323,087 issued and outstanding as of June 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$29.13K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$115.91M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$168.50M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-135.31M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-104.79M	USD	Point-in-time
Total stockholders' equity attributable to BioSig Technologies, Inc.	`StockholdersEquity`	$11.15M	USD	Point-in-time
Total stockholders' equity attributable to BioSig Technologies, Inc.	`StockholdersEquity`	$33.22M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$514.83K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$2.79M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.01M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.32M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.85M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.97M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$10.19M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$14.22M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$39.81M	USD	Point-in-time

Income Statement 64 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$3.31M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$5.72M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.82M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$10.64M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$16.61M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$10.54M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$24.46M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$6.16M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$9.98K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$43.22K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$22.21K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$17.91K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$22.35M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$7.99M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$13.86M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$35.15M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-22.35M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-7.99M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-13.86M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-35.15M	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$43.03K	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$3.45K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$39.15K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$45.27K	USD	2 Qtrs
Loss on foreign currency translation	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Loss on foreign currency translation	`GainLossOnDispositionOfAssets1`	$-1.16K	USD	2 Qtrs
Loss on foreign currency translation	`GainLossOnDispositionOfAssets1`	$-1.16K	USD	1 Quarter
Loss on foreign currency translation	`GainLossOnDispositionOfAssets1`	-	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-13.82M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-7.95M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-22.35M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-35.11M	USD	2 Qtrs
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`ProfitLoss`	$-35.11M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-7.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-22.35M	USD	1 Quarter
Net loss	`ProfitLoss`	$-13.82M	USD	2 Qtrs
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-4.59M	USD	2 Qtrs
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-3.16M	USD	1 Quarter
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-13.82M	USD	2 Qtrs
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-30.52M	USD	2 Qtrs
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-7.95M	USD	1 Quarter
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-19.19M	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$4.87K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$4.70K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$9.32K	USD	2 Qtrs
Preferred stock dividend	`DividendsPreferredStock`	$15.41K	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-30.53M	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-7.95M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-13.83M	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-19.19M	USD	1 Quarter
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.38	USD	1 Quarter
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.20	USD	2 Qtrs
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.72	USD	2 Qtrs
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.72	USD	1 Quarter
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	26.54M	shares	1 Quarter
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	20.67M	shares	1 Quarter
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	25.46M	shares	2 Qtrs
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	19.27M	shares	2 Qtrs

Cash Flow Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-35.11M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-7.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-22.35M	USD	1 Quarter
Net loss	`ProfitLoss`	$-13.82M	USD	2 Qtrs
Depreciation	`DepreciationDepletionAndAmortization`	$9.98K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$43.22K	USD	2 Qtrs
Depreciation	`DepreciationDepletionAndAmortization`	$22.21K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$17.91K	USD	2 Qtrs
Equity based compensation	`AllocatedShareBasedCompensationExpense`	$15.74M	USD	2 Qtrs
Equity based compensation	`AllocatedShareBasedCompensationExpense`	$5.73M	USD	2 Qtrs
Change in fair value of modified options	`OtherNoncashExpense`	-	USD	2 Qtrs
Change in fair value of modified options	`OtherNoncashExpense`	$666.06K	USD	2 Qtrs
Fair value of subsidiary stock issued to acquire research and development	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$3.17M	USD	2 Qtrs
Fair value of subsidiary stock issued to acquire research and development	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	2 Qtrs
Fair value of subsidiary stock issued to acquire research and development	`ShareBasedCompensation`	-	USD	2 Qtrs
Fair value of subsidiary stock issued to acquire research and development	`ShareBasedCompensation`	$1.30M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$222.31K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	-	USD	2 Qtrs
Vendor deposits	`IncreaseDecreaseInDepositsOutstanding`	$470.83K	USD	2 Qtrs
Vendor deposits	`IncreaseDecreaseInDepositsOutstanding`	-	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$299.19K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$159.07K	USD	2 Qtrs
Deposits	`IncreaseDecreaseInDepositOtherAssets`	-	USD	2 Qtrs
Deposits	`IncreaseDecreaseInDepositOtherAssets`	$69.76K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-8.41K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.62M	USD	2 Qtrs
Lease liability, net	`IncreaseDecreaseInOtherOperatingLiabilities`	$1.32K	USD	2 Qtrs
Lease liability, net	`IncreaseDecreaseInOtherOperatingLiabilities`	$3.39K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-14.22M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.64M	USD	2 Qtrs
Payments of patent costs	`PaymentsToAcquireIntangibleAssets`	-	USD	2 Qtrs
Payments of patent costs	`PaymentsToAcquireIntangibleAssets`	$111.32K	USD	2 Qtrs
Payment of trademark costs	`PaymentsToAcquireOtherProductiveAssets`	$275.00	USD	2 Qtrs
Payment of trademark costs	`PaymentsToAcquireOtherProductiveAssets`	-	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$28.09K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$45.24K	USD	2 Qtrs
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-156.83K	USD	2 Qtrs
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-28.09K	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$8.62M	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$16.16M	USD	Point-in-time
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$25.21M	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$9.05M	USD	Point-in-time
Proceeds from sale of subsidiary stock to non-controlling interest, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$10.59M	USD	2 Qtrs
Proceeds from sale of subsidiary stock to non-controlling interest, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	2 Qtrs
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$2.23M	USD	1 Quarter
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$444.84K	USD	1 Quarter
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$444.84K	USD	2 Qtrs
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$2.23M	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$4.62M	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$1.03M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$39.07M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.68M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$5.88M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$24.82M	USD	2 Qtrs
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$12.11M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.45M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$10.33M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$36.93M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$12.11M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.45M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$10.33M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$36.93M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	-	USD	2 Qtrs
Cash paid during the period for interest	`InterestPaidNet`	-	USD	2 Qtrs
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$9.32K	USD	2 Qtrs
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$15.41K	USD	2 Qtrs
Right-to-use assets and lease liability recorded upon adoption of ASC 842	`OtherSignificantNoncashTransactionValueOfConsiderationReceived1`	-	USD	2 Qtrs
Right-to-use assets and lease liability recorded upon adoption of ASC 842	`OtherSignificantNoncashTransactionValueOfConsiderationReceived1`	$422.21K	USD	2 Qtrs
Record right-to-use assets and related lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	2 Qtrs
Record right-to-use assets and related lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$506.28K	USD	2 Qtrs

Stockholders Equity 55 line items

Line Item	Tag	Value	Unit	Period
Common stock issued upon exercise of options at an average of per share	`ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisePrice`	$4.66	USD	Point-in-time
Common stock issued upon exercise of options at an average of per share	`ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisePrice`	$4.66	USD	Point-in-time
Common stock issued upon exercise of options at an average of per share	`ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisePrice`	$4.76	USD	Point-in-time
Common stock issued upon exercise of options at an average of per share	`ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisePrice`	$10.49	USD	Point-in-time
Common stock issued upon exercise of warrants at an average of per share	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$5.00	USD	Point-in-time
Common stock issued upon exercise of warrants at an average of per share	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$10.00	USD	Point-in-time
Common stock issued upon exercise of warrants at an average of per share	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$3.75	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.97M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$10.19M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.32M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.01M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.85M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	23.32M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	29.13M	shares	Point-in-time
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$25.21M	USD	2 Qtrs
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$16.16M	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$8.62M	USD	2 Qtrs
Sale of common stock (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	2.19M	shares	Point-in-time
Sale of common stock (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	2.50M	shares	Point-in-time
Sale of subsidiary shares to non-controlling interest	`ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityBySubsidiaryToNoncontrollingInterests`	$10.59M	USD	1 Quarter
Sale of subsidiary shares to non-controlling interest	`ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityBySubsidiaryToNoncontrollingInterests`	$10.59M	USD	2 Qtrs
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$108.27K	USD	2 Qtrs
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$2.33M	USD	2 Qtrs
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$108.27K	USD	1 Quarter
Common stock issued for services (in Shares)	`StockIssuedDuringPeriodSharesIssuedForServices`	15,038.00	shares	2 Qtrs
Fair value of subsidiary shares issued to acquire research and development	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$1.30M	USD	2 Qtrs
Fair value of subsidiary shares issued to acquire research and development	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$1.30M	USD	1 Quarter
Change in fair value of modified options	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$666.06K	USD	1 Quarter
Change in fair value of modified options	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$666.06K	USD	2 Qtrs
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.22M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.06M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.39M	USD	2 Qtrs
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.64M	USD	2 Qtrs
Preferred Stock dividend	`DividendsPreferredStock`	$4.87K	USD	1 Quarter
Preferred Stock dividend	`DividendsPreferredStock`	$4.70K	USD	1 Quarter
Preferred Stock dividend	`DividendsPreferredStock`	$9.32K	USD	2 Qtrs
Preferred Stock dividend	`DividendsPreferredStock`	$15.41K	USD	2 Qtrs
Net loss	`ProfitLoss`	$-22.35M	USD	1 Quarter
Net loss	`ProfitLoss`	$-13.82M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-7.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-35.11M	USD	2 Qtrs
Common stock issued upon exercise of options	`ProceedsFromStockOptionsExercised`	$2.23M	USD	1 Quarter
Common stock issued upon exercise of options	`ProceedsFromStockOptionsExercised`	$444.84K	USD	1 Quarter
Common stock issued upon exercise of options	`ProceedsFromStockOptionsExercised`	$444.84K	USD	2 Qtrs
Common stock issued upon exercise of options	`ProceedsFromStockOptionsExercised`	$2.23M	USD	2 Qtrs
Common stock issued upon exercise of options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	1.09M	shares	2 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.01M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.32M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.85M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.97M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$10.19M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	23.32M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	29.13M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.